GNPX Trade on Feb 18, 2020 10:01 from beno: Tradervue User Stock Trades.

Gravatar

Shared by
beno

 

Fundamentals

Shares Outstanding: 19.3m
Cash: 2.55m (+ $8m from Jan 28 offering)
Current liabilities: 537k
Current ratio: 6.72
NWC (total current assets - total current liabilities): 3.07m
Monthly Burn rate (net loss / months): 578k
Estimated current cash: 527k
Accumulated deficit: 38m
Book value (Stock holder equity / Shares outstanding): 0.223

Catalysts / News / Painting the picture

-Receives FDA Fast track for its Oncorpex Immunogene therapy that targets lung cancer
-Sign Exclusive License Agreement with University of Pittsburgh for Potentially Curative Gene Therapy Candidate for Diabetes
-$25m shelf, recent offering 17/01/20 for $1.267m
-2020-01-28: Closes $8m offering
-Enough cash for 13 months

Technical Analysis

-Levels: 4.20, 4.70, 5, 5.40

Original Plan / Strategy

First Test Long of 4.70 by 4.60 zone

Review

Was not expecting a retracement to 4.50, tried to mitigate my loss when stock popped back into the 4.60s.

image


Execution detail:

Date/time Symbol Side Price Position
2020-02-18 10:01:35 GNPX buy $4.720 long
2020-02-18 10:01:40 GNPX buy $4.660 long
2020-02-18 10:01:40 GNPX buy $4.680 long
2020-02-18 10:01:40 GNPX buy $4.610 long
2020-02-18 10:04:04 GNPX sell $4.630 0


Leave a comment about this trade!

You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes just a few seconds to sign up, and it's free!

View plans, Sign up for free, or Log in